malaria vaccine

    Are GlaxoSmithKline's Do-Gooder Moves Genuine or Just Good PR?

    By Melly Alazraki

    | 10:00AM 1/21/2010
    He's young, charismatic, innovative and has got heart. At least that's the impression GlaxoSmithKline CEO Andrew Witty gives to the outside world. GSK is allowing free access to its library of 13,500 potential malaria treatments. Is he genuinely a do-gooder or just good at PR?
    Continue reading »